These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18469837)

  • 21. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
    Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
    Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolic syndrome is not a sensible tool for predicting the risk of coronary heart disease.
    Woodward M; Tunstall-Pedoe H
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):210-4. PubMed ID: 19305352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominal obesity and metabolic syndrome.
    Després JP; Lemieux I
    Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolic syndrome: mechanisms, epidemiology, and clinical implications.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):17-27. PubMed ID: 19667650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology.
    Després JP; Cartier A; Côté M; Arsenault BJ
    Ann Med; 2008; 40(7):514-23. PubMed ID: 18608131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does diagnosis of metabolic syndrome predict the likelihood of peripheral arterial disease as defined by a low ankle-brachial index?
    López-Suárez A; Beltrán-Robles M; Elvira-González J; Alwakil M; Bascuñana-Quirell A; Rosal-Obrador J; Badani-Gutiérrez H; Oliver-Pece M; Pons-Raga A; Ruiz-DeCastroviejo J; Cañas-Hormigo F; Benítez-Rodríguez E
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):693-7. PubMed ID: 18756176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk in patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Bascaran MT; Martínez A S; Benabarre A; Sierra P; Torres P; Montes JM; Bousoño M; Bobes J;
    J Affect Disord; 2009 Jun; 115(3):302-8. PubMed ID: 18954911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
    Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waist circumference home measurement--a device to find out patients in cardiovascular risk.
    Korhonen PE; Jaatinen PT; Aarnio PT; Kantola IM; Saaresranta T
    Eur J Public Health; 2009 Jan; 19(1):95-9. PubMed ID: 18927187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between peripheral arterial disease and metabolic syndrome.
    Maksimovic M; Vlajinac H; Radak D; Marinkovic J; Jorga J
    Angiology; 2009; 60(5):546-53. PubMed ID: 19147526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome.
    Rosolova H; Petrlova B; Simon J; Sifalda P; Sipova I
    Med Sci Monit; 2008 Aug; 14(8):CR411-5. PubMed ID: 18667998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
    Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP
    Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the metabolic syndrome on the patients with acute coronary syndrome.
    Agoşton-Coldea L; Mocan T; Rusu LD; Pais R; Albu A; Rusu ML; Perna S
    Rom J Intern Med; 2008; 46(1):55-62. PubMed ID: 19157271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified metabolic syndrome criteria for identification of patients at risk of developing diabetes and coronary heart diseases: longitudinal assessment via electronic health records.
    Hivert MF; Dusseault-Bélanger F; Cohen A; Courteau J; Vanasse A
    Can J Cardiol; 2012; 28(6):744-9. PubMed ID: 22552176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
    J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
    Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
    J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms.
    Esquirol Y; Bongard V; Mabile L; Jonnier B; Soulat JM; Perret B
    Chronobiol Int; 2009 Apr; 26(3):544-59. PubMed ID: 19360495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
    Schneiderhan ME; Batscha CL; Rosen C
    Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.